Company intelligence / Profile preview
Eurocine Vaccines AB
Solna, Stockholms län, Swedeneurocine-vaccines.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Eurocine Vaccines is a clinical-stage company that develops vaccines up to proof of concept (clinical phase I/II) and then licenses them to partners for further development and commercialization. Their proprietary adjuvant technology Endocine™ has been tested in four extensive clinical studies with over 400 subjects.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Nasal vaccinesmRNA vaccinesProtein-based vaccines
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Redbiotec AGSpixia Biotechnology
Beyond the preview
Go deeper on Eurocine Vaccines AB.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eurocine Vaccines AB.